Suppr超能文献

肺外周非小细胞癌患者行肺切除术后切缘细胞学检查结果及切缘/肿瘤大小比值的临床意义。

Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer.

机构信息

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

出版信息

Surg Today. 2012 Feb;42(3):238-44. doi: 10.1007/s00595-011-0031-6. Epub 2011 Nov 10.

Abstract

PURPOSE

A pulmonary wedge resection is useful for the treatment of peripheral non-small cell lung cancer (NSCLC). The margin/tumor size ratio (M/T) is a predictor of positive margin cytology findings in these procedures, although the long-term clinical implications remain unclear. This relationship was investigated in this study.

METHODS

Thirty-seven cases with a high surgical risk without additional pulmonary resection were selected from those accrued in a multicenter prospective study of optimal margin distance for pulmonary excision of peripheral NSCLC and followed for more than 5 years (range 5.3-14 years).

RESULTS

Both the M/T and margin cytology findings were indicators of cancer recurrence and survival. All seven cases of surgical margin recurrence had a cytology-positive surgical margin. The 5-year survival rate was 54.2% (n = 24) for M/T < 1 and 84.6% for M/T ≥ 1 (n = 13, P = 0.05), while it was 38.5% for positive margin (n = 13) and 79.2% for negative margin (n = 24) cases (P = 0.001). In addition, the margin cytology findings were an independent prognostic factor.

CONCLUSION

A pulmonary wedge resection for peripheral NSCLC should result in a negative malignant margin, which might be obtained from a sufficient tumor margin ratio of M/T ≥ 1.

摘要

目的

肺楔形切除术可用于治疗周围型非小细胞肺癌(NSCLC)。切缘/肿瘤大小比(M/T)是预测这些手术中阳性切缘细胞学发现的指标,尽管其长期临床意义尚不清楚。本研究对此进行了调查。

方法

从多中心前瞻性研究中选择了 37 例具有高手术风险但无需额外肺切除术的患者,这些患者入组了一项关于周围型 NSCLC 肺切除最佳切缘距离的多中心前瞻性研究,随访时间超过 5 年(范围 5.3-14 年)。

结果

M/T 和切缘细胞学发现均是癌症复发和生存的指标。所有 7 例手术切缘复发患者均有细胞学阳性的手术切缘。M/T<1 的 5 年生存率为 54.2%(n=24),M/T≥1 的 5 年生存率为 84.6%(n=13,P=0.05),而阳性切缘的 5 年生存率为 38.5%(n=13),阴性切缘的 5 年生存率为 79.2%(n=24)(P=0.001)。此外,切缘细胞学发现是一个独立的预后因素。

结论

肺楔形切除术治疗周围型 NSCLC 应获得阴性的恶性切缘,这可能通过 M/T≥1 的足够肿瘤切缘比获得。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验